Change in Management - resignation of Mr . Devanshu Ravinder Dange from the position of Company secretary, compliance officer and KMP w.e.f. closing business hours of July 31, 2025 due to personal reasons and appointment of Mr. Shailendra vyas as Company Secretary, Compliance officer and KMP of the Company w.e.f. August 01, 2025.

pdf

Hindustan Bio Sciences Ltd.

31 Jul 2025

8.12

-4.58%

Company Update

Hindustan Bio Sciences Ltd - 532041 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / …

BSE India

The Board of Directors of the company in its meeting held today on July 31, 2025 have taken note of resignation of Mr. Devanshu Ravinder Dange (A76053) from the position of Company Secretary, Compliance officer and Key Managerial Personnel of the company with effect from the closing business hours of July 31, 2025 due to personal reasons. His resignation letter is attached as annexure 2 to the outcome.

pdf

Hindustan Bio Sciences Ltd.

31 Jul 2025

8.12

-4.58%

Company Update

Hindustan Bio Sciences Ltd - 532041 - Appointment of Company Secretary and Compliance Officer

BSE India

The Board of Directors in its meeting held today on July 31, 2025 have appointed Mr. Shailendra Vyas, Associate member of ICSI, having membership number - A77193 as Company Secretary, Compliance Officer and Key Managerial Personnel of the Company with effect from August 01, 2025.

pdf

Hindustan Bio Sciences Ltd.

31 Jul 2025

8.12

-4.58%

Result

Hindustan Bio Sciences Ltd - 532041 - Un-Audited Standalone Financial Results For The First Quarter Ended …

BSE India

The board of Directors in its meeting held on Thursday, July 31, 2025 approved the Un-audited Standalone Financial Results of the Company for the First Quarter ended on June 30, 2025.

pdf

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	0.34	0.39	0.43	-12.8%	-20.9%
Operating Profit Qtr	0.00	0.10	0.07	-	-
Net Profit Qtr	0.01	0.11	0.08	-90.9%	-87.5%
Earning Per Share Adjusted latest Qtr	0.01	0.11	0.08	-90.9%	-87.5%

* Standalone data

Detailed Results

Hindustan Bio Sciences Ltd.

31 Jul 2025

8.12

-4.58%

Board Meeting

Hindustan Bio Sciences Ltd - 532041 - Board Meeting Outcome for Outcome Of The Board Meeting …

BSE India

Pursuant to Regulation 30 and other applicable Regulations of SEBI (LODR), 2015, the Board of Directors of the Company in its meeting held today i.e., on July 31, 2025: Approved the Un-Audited Standalone Financial Results of the company for the First Quarter ended on June 30, 2025 along with the Limited Review Report and considered other items as mentioned in the outcome PDF.

pdf

Hindustan Bio Sciences Ltd.

19 Jul 2025

8.12

-4.58%

Board Meeting

Hindustan Bio Sciences Ltd - 532041 - Board Meeting Intimation for Considering The Un-Audited Standalone Financial …

BSE India

Hindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 ,inter alia, to consider and approve the following: 1. Un-audited financial results of the company for the first quarter ended on 30-06-2025, 2 Any other matter with the permission of Chair.

pdf

Hindustan Bio Sciences Ltd.

17 Jul 2025

8.12

-4.58%

Company Update

Hindustan Bio Sciences Ltd - 532041 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

We are submitting herewith the Certificate issued by Venture Capital and Corporate Investments Private Limited in compliance with Regulation 74(5) of the SEBI (D&P) Regulations, 2018 for the first quarter ended on June 30, 2025.

pdf

Hindustan Bio Sciences Ltd.

26 Jun 2025

8.12

-4.58%

SAST

Hindustan Bio Sciences Ltd - 532041 - Closure of Trading Window

BSE India

This is to inform that the trading window for dealing in the securities of the Company will remain closed from July 01, 2025 till 48 hours after the announcement of Standalone Unaudited Financial Results for the 1st Quarter ending on June 30, 2025

pdf

Hindustan Bio Sciences Ltd.

07 Jun 2025

8.12

-4.58%

Company Update

Hindustan Bio Sciences Ltd - 532041 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publication

pdf

Is Hindustan Bio Sciences Ltd. worth buying?

10 Votes:

Buy 40.0%

Sell 50.0%

Hold 10.0%